Cargando…
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo
Mycetoma is a neglected tropical disease commonly caused by the fungus Madurella mycetomatis. Standard treatment consists of extensive treatment with itraconazole in combination with surgical excision of the infected tissue, but has a low success rate. To improve treatment outcomes, novel treatment...
Autores principales: | Konings, Mickey, Eadie, Kimberly, Strepis, Nikolaos, Nyuykonge, Bertrand, Fahal, Ahmed H, Verbon, Annelies, van de Sande, Wendy W J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684268/ https://www.ncbi.nlm.nih.gov/pubmed/37960934 http://dx.doi.org/10.1093/mmy/myad118 |
Ejemplares similares
-
Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella
por: Lim, Wilson, et al.
Publicado: (2022) -
Madurella mycetomatis grains within a eumycetoma lesion are clonal
por: Nyuykonge, Bertrand, et al.
Publicado: (2022) -
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim
por: Lim, Wilson, et al.
Publicado: (2020) -
The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach
por: Lim, Wilson, et al.
Publicado: (2020) -
Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma
por: Nyuykonge, Bertrand, et al.
Publicado: (2022)